Emergency Preparedness and Response
Resources for You
MCMi Professional Development Activities
FDA's Strategic Plan: 2012 to 2016 (PDF, 632.18 KB)
- Foundations for Pre-Clinical Review lecture series: A monthly lecture series on pre-clinical scientific and technical issues. Goals include examining common study pitfalls and supporting consistent guidance development. Presentations are invited from both internal and external experts in the field. Although occasionally open to the public, most lectures are for FDA staff.
- MCM Lecture Series: These lectures broaden the understanding of the policies, procedures, and US governmental framework for FDA reviewers who are assessing applications for medical products to counter CBRN threats. Lectures are presented by highly respected leaders in their fields.
- Conference Support: During the year, MCMi staff attend key MCM-related external conferences (e.g., the ASM Biodefense and Emerging Diseases Research meeting, the Biodefense Vaccines and Therapeutics and Biosecurity workshop).
- Threat briefings: By outside experts in their fields; briefings bring the latest scientific and technical information on biosecurity issues to FDA staff.
- MCMi Hot Topics: Are timely, scientific briefings on MCM-related topics of interest to FDA staff involved in the review of medical product applications. Subject matter experts from from Federal agencies, academia, and regulated industry are invited to speak on issues that are not product specific.
- Georgetown University Certificate Program on Biohazardous Threat Agents and Emerging Infectious Diseases: This 12-credit, on-line, graduate level certificate program is available to FDA staff involved in MCMi activities who want to learn more about the science behind and impact of biothreat agents and emerging diseases. Upon successful course completion, participants receive a Certificate in Biohazardous Threat Agents and Emerging Diseases.
- MCMi regulatory science research, including collaborative research at the annual MCMi Regulatory Science Symposium.
- GLP Training: FDA and the University of Texas Medical Branch, Galveston National Laboratory (UTMB - GNL) are planning a collaboration to provide training in how to meet Good Laboratory Practice (GLP) requirements (PDF, 204.83 KB) in high and maximum biocontainment security level (BSL)-4 laboratory facilities. The new training program will be open to all interested parties.
- Continuing Education: Whenever feasible, FDA offers continuing education credits to physicians, nurses, pharmacists, and veterinarians who attend these professional development activities.